Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies

Formoterol in the treatment of experimental cancer cachexia: effects on heart function

(2014) Míriam Toledo et al.   Journal of Cachexia Sarcopenia and Muscle

Muscle wasting in heart failure: An overview

(2013) Stephan von Haehling et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Mitochondrial dysfunction and sarcopenia of aging: From signaling pathways to clinical trials

(2013) Emanuele Marzetti et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Resting Energy Expenditure and the Effects of Muscle Wasting in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF)

(2013) Matthias Tacke et al.   Journal of the American Medical Directors Association

Prevalence of Sarcopenia in Community-Dwelling Japanese Older Adults

(2013) Minoru Yamada et al.   Journal of the American Medical Directors Association

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

(2013) Adrian S Dobs et al.   LANCET ONCOLOGY

Mechanism and novel therapeutic approaches to wasting in chronic disease

(2013) Nicole Ebner et al.   MATURITAS

TGF-b Superfamily Cytokine MIC-1/GDF15 Is a Physiological Appetite and Body Weight Regulator

(2013) Vicky Wang-Wei Tsai et al.   PLoS One

Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3-creatine dilution method

(2013) Stephen A. Stimpson et al.   Journal of Cachexia Sarcopenia and Muscle

Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)

(2012) S. Fulster et al.   EUROPEAN HEART JOURNAL

Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients

(2012) Stefan Hettwer et al.   EXPERIMENTAL GERONTOLOGY

Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference

(2012) Nicole Ebner et al.   Journal of Cachexia Sarcopenia and Muscle

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer:

(2011) Andrew J. Stewart Coats et al.   Journal of Cachexia Sarcopenia and Muscle

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

(2011) James T. Dalton et al.   Journal of Cachexia Sarcopenia and Muscle

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)

(2010) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Cachexia: A new definition

(2008) William J. Evans et al.   CLINICAL NUTRITION